Search Results 1211-1220 of 19357 for hemoglobin

1. Dapagliflozin (DAPA) Effects in HFpEF - Clinical Trials

   Severe anemia (hemoglobin < 9 gm/dl). Significant left-sided valvular heart disease (> moderate stenosis, > moderate regurgitation). Severe kidney disease ...

2. Ezetimibe (oral route) - Side effects & dosage - Mayo Clinic

   Description. Ezetimibe is used alone or combination with diet and other cholesterol-lowering medicines (eg, fenofibrate, statins) to treat high cholesterol ...

3. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 10 g/dL; Creatinine ≤ 1.5 times the upper limit of normal with creatinine clearance ≥ 50 mL/min using the Modified Cockcroft-Gault method ...

4. Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers - Mayo Clinic

   Absolute neutrophil count (ANC) \< 1.5 x 109/L, hemoglobin \< 10 g/dL, or platelet count \< 100 x 109/L * QT interval corrected by Fridericia's formula ...

5. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Total bilirubin ≤ 1.5 X upper limit of normal (ULN); if total bilirubin > 1.5 X ULN then direct bilirubin ≤ ULN;; Aspartate ...

6. Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (may receive RBC transfusions). Adequate Renal Function Defined As: Creatinine clearance or radioisotope GFR ≥ 70 mL/min/1.73 m^2 ...

7. Metabolic syndrome - Symptoms & causes - Mayo Clinic

   Having three or more specific risk factors, such as high blood pressure or abdominal fat, boosts your risk of type 2 diabetes and heart disease.

8. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; subjects with hemoglobin ≥ 8-9 g/dL may be included with approval from the Medical Monitor;; In subjects transfused before study entry ...

9. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN), (≤ 3 x ULN if Gilbert's disease);; Aspartate transaminase (AST) 3 x ULN ( ≤ 5 ...

10. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

    Hemoglobin <11 g/dL. Signs of hemolysis with abnormal values by any of the following hemolytic markers: Increased absolute reticulocyte counts (above ULN); ...